Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 23

Citing Papers

Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies
2024 Standout
2 intermediate papers

Works of Morihiro Iwata being referenced

[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].
2006
Evaluation of a new agar medium containing cetrimide, kanamycin and nalidixic acid for isolation and enhancement of pigment production of Pseudomonas aeruginosa in clinical samples
2003

Author Peers

Author Last Decade Papers Cites
Morihiro Iwata 117 98 55 71 17 308
Myron W. Fisher 92 99 36 85 23 354
Edward R. Bannister 132 92 68 37 25 371
Frédéric Ballester 114 48 52 65 14 299
M. A. McCrackin Stevenson 76 80 37 38 13 363
Elżbieta Stefaniuk 152 139 104 55 18 358
Deena Sutter 90 135 73 64 14 326
D. E. Healing 72 52 33 51 14 290
Jun-Hee Woo 124 76 41 42 12 333
Lisa Avery 74 77 45 65 22 338
Chendi Zhu 97 108 15 54 30 298

All Works

Loading papers...

Rankless by CCL
2026